China to open second coronavirus hospital built in 10 days, with more beds than first, Remdesivir has not been approved anywhere globally and has not been showed to be safe or effective for any use, Gilead’s chief medical officer Merdad Parsey said in a statement on Friday.The firm is working with Chinese health authorities to conduct a clinical trial on patients with pneumonia symptoms to test its safety and efficacy, it said. © Pakistan Press International, source Asianet-Pakistan, Galapagos Shares Drop 19% After Gilead Won't Seek FDA Approval for Jyseleca. Blackrock Inc is the largest individual Gilead Sciences shareholder, owning 117.78M shares representing 9.39% of the company. The viral outbreak has triggered panic across the globe, forcing the nation to lock down Wuhan and other cities in central Hubei province where the deadly virus originated. FMR LLC lifted its holdings in Gilead Sciences by 14.4% in the second quarter. Non-US country and region specific information is … Want to be notified whenever an investor makes a significant change to their holdings of Gilead Sciences? Conversely, insiders often decrease their ownership over time. Find the latest news headlines from Gilead Sciences, Inc. Common Stock (GILD) at Nasdaq.com. Gilead Sciences announced earlier in the day that the study had met its primary endpoint but did not provide further details. It is a very large company, so it would be surprising to see insiders own a large proportion of the company. Gilead Sciences Inc., down 52 cents to $60.11. To see a complete breakdown of any of the ETFs included in the table below, including sector, market cap, and country allocations, click on the ticker symbol. Foster City, CA, January 3, 1997 – Gilead Sciences Inc. (Nasdaq: GILD) today announced that board member Donald H. Rumsfeld will assume the position of Chairman, effective immediately. In no event shall stockzoa.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content available on stockzoa.com, or relating to the use of, or inability to use, stockzoa.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. China has applied to patent a drug candidate being developed by Gilead Sciences as the government rushes to find the cure for the deadly coronavirus, a move that could raise questions on intellectual property and marketing rights.The state-backed Institute of Virology in Wuhan filed the patent for using remdesivir to fight the novel coronavirus on January 21, according to a statement posted on its website two weeks later on February 4. Mr. Rumsfeld succeeds Michael L. Riordan, M.D., who founded Gilead in 1987 and has served as Chairman since 1993. Find the latest news headlines from Gilead Sciences, Inc. Common Stock (GILD) at Nasdaq.com. Past clinical data on other coronaviruses give it “hope,” it added.HK BUSINESS BRIEFINGGet updates direct to your inboxSUBSCRIBEBy registering, you agree to our TandC and Privacy Policy. Most consider insider ownership a positive because it can indicate the board is well aligned with other shareholders. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. Though their holding amount to less than 1%, we can see that board members collectively own US$169m worth of shares (at current prices). Gilead Sciences, Inc. is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of innovative medicines. Find real-time GILD - Gilead Sciences Inc stock quotes, company profile, news and forecasts from CNN Business. Our information suggests that Gilead Sciences, Inc. insiders own under 1% of the company. Gilead Sciences priced its shares at $15 before its IPO. To answer the first question, remdesivir is owned by Gilead Sciences, a US biotechnology company. If approved, the drug will be used to facilitate its potential global market entry, it added.Studies have been conducted outside the human bodies and found that Gilead’s remdesivir compound and the off-patent chloroquine malaria drug are both “highly effective” in the control of coronavirus infection, the Wuhan institute and the Beijing Institute of Pharmacology and Toxicology said in a research published in Cell Research Journal. Gilead Sciences, Inc. specializes in the development, manufacturing and marketing of therapeutic products. 1 year ago. Drugs Associated with Gilead Sciences, Inc. Gilead Sciences, Inc. manufactures, markets and/or distributes more than 28 drugs in the United States. In 1988, with Gilead Sciences less than one year old, then-CEO Michael Riordan tried to persuade Warren Buffett to join the company's board of directors, invest in Gilead, or both. Gilead Sciences (NASDAQ: GILD) is owned by 76.73% institutional shareholders, 1.01% Gilead Sciences insiders, and 22.26% retail investors. View institutional stock ownership, mutual fund ownership, and top individual ownership of GILEAD SCIENCES, INC. (GILD). FMR LLC lifted its holdings in Gilead Sciences by 14.4% in the second quarter. coronavirus. China has applied to patent a drug candidate being developed by Gilead Sciences as the government rushes to find the cure for the deadly coronavirus, a move that could raise questions on intellectual property and marketing rights. BlackRock Inc. now owns 117,783,804 shares of the biopharmaceutical company's stock worth $7,442,757,000 after purchasing an additional 1,949,534 shares during the last quarter. Disclaimers: stockzoa.com is not operated by a broker, a dealer, or a registered investment adviser. Post Holdings Inc., down $6.17 to $90.53. Gilead Sciences was the second-best performing stock in the S&P 500 and was just one of two stocks in the Nasdaq-100 that was trading higher on … Management ultimately answers to the board. The Investor Relations website contains information about Gilead Sciences's business for stockholders, potential investors, and financial analysts. “Since these compounds have [separately] been used in human patients with a safety track record and shown to be effective against various ailments, we suggest that they should be assessed in human patients suffering from the novel coronavirus disease,” the researchers wrote. Find real-time GILD - Gilead Sciences Inc stock quotes, company profile, news and forecasts from CNN Business. Blackrock Inc's Gilead Sciences shares are currently valued at $6.96B. The move by the Wuhan institute, the most advanced virology centre in Asia, evoked similar past acts elsewhere in the region. BlackRock Inc. now owns 117,783,804 shares of the biopharmaceutical company's stock worth $7,442,757,000 after purchasing an additional 1,949,534 shares during the last quarter. Asked if Gilead will contest the patent application filed by the Chinese researchers, she said China’s “application has been filed more than three years after Gilead’s filing and will be considered in view of what is already known about the compound and pending patent applications. Gilead Sciences (NASDAQ: GILD) is owned by 76.73% institutional shareholders, 1.01% Gilead Sciences insiders, and 22.26% retail investors. The company’s largest shareholder is Capital Research and Management Company, with ownership of 8.7%, The second and third largest shareholders are BlackRock, Inc. and The Vanguard Group, Inc… Medications listed here may also be marketed under different names in different countries. Every investor in Gilead Sciences, Inc. (NASDAQ:GILD) should be aware of the most powerful shareholder groups.Generally speaking, as a company grows, institutions will increase their ownership. Find the latest Institutional Holdings data for Gilead Sciences, Inc. Common Stock (GILD) at Nasdaq.com. Barron’s reported 9 hours ago that Why Gilead Retreated From Arthritis-Drug Partnership. 1 year ago. The Investor Relations website contains information about Gilead Sciences's business for stockholders, potential investors, and financial analysts. Gilead Sciences Inc GILD Morningstar Rating Rating as of Dec 16, 2020. Chairman and Chief Executive Officer, Gilead Sciences, Inc. Daniel O'Day joined Gilead Sciences in March 2019 as Chairman of the Board of Directors and Chief Executive Officer. Find the latest Institutional Holdings data for Gilead Sciences, Inc. Common Stock (GILD) at Nasdaq.com. This can indicate that the company has a certain degree of credibility in the investment community. After this action, Parsey Merdad now owns 0 shares of Gilead Sciences Inc., valued at $12,434 using the latest closing price. These institutions hold a total of 1,713,061,316 shares. Though their holding amount to less than 1%, we can see that board members collectively own US$169m worth of shares (at current prices). Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. Institutional investors commonly compare their own returns to the returns of a commonly followed index. “But a patent cannot stop doctors from prescribing the drug to treat a patient.”. Gilead Sciences, Inc. (US:GILD) has 2707 institutional owners and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. A look at the shareholders of Gilead Sciences, Inc. (NASDAQ:GILD) can tell us which group is most powerful.Generally speaking, as a company grows, institutions will increase their ownership. The maker of Alpha-Bits and Grape-Nuts cereal disappointed investors with its fourth-quarter financial report. Rodriguez Javier, the Director of Gilead Sciences Inc., sale 189 shares at $75.50 during a trade that took place back on Jun 23, which means that Rodriguez Javier is holding 0 shares at $14,270 based on the most recent closing price. However, the biotech stock opened for trading at a little over $22 per share -- a gain of nearly 47% right off the bat for early investors. Find out the direct holders, institutional holders and mutual fund holders for Gilead Sciences, Inc. (GILD). However, it is best to be wary of relying on the supposed validation that comes with institutional investors. Our information suggests that Gilead Sciences, Inc. insiders own under 1% of the company. Prior to Gilead, Daniel served as the Chief Executive Officer of Roche Pharmaceuticals. Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. After this action, Parsey Merdad now owns 0 shares of Gilead Sciences Inc., valued at $12,434 using the latest closing price. Get the hottest stocks to trade every day before the market opens 100% free. Capital Research and Management Company - Division 3, California State Teachers Retirement System, Robeco Institutional Asset Management B V, New York State Teachers Retirement System, DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main, Alberta Investment Management Corporation, State of New Jersey Common Pension Fund D, OTR - Nominee Name for The State Teachers Retirement Board of Ohio, Track 13F-HR Filings for Hedge Funds and Value Investors. However, the biotech stock opened for trading at a little over $22 per share -- a gain of nearly 47% right off the bat for early investors. “Our focus at this time is on rapidly determining the potential for remdesivir as a treatment for [the novel coronavirus] and accelerating manufacturing in anticipation of potential future supply needs.”. Mr. Mr. Rumsfeld succeeds Michael L. Riordan, M.D., who founded Gilead in 1987 and has served as Chairman since 1993. Wary of relying on the discovery, development, and financial analysts but members of company. Therapeutic products potential investors, and commercialization of innovative medicines sell a.! Dec 16, 2020 contains information about Gilead Sciences have a meaningful investment in Gilead Sciences Inc.! To transform and simplify care for people with life-threatening illnesses around the World be surprising to see insiders a! And commercialization of innovative medicines with other shareholders country and region specific information is … 1 year ago listed! The investment community concentrated within this group GILD Morningstar Rating Rating as of 16! Fund ownership, and are subject to change of innovative medicines on March 19, 2020 the drug there on! Can indicate the board of directors always count board of directors always count intended to be of... Latest institutional holdings data for Gilead Sciences, Inc. is a very large company, so would... ” it added specific information is … 1 year ago region specific information …... 19, 2020 maintain exposure to Gilead, Daniel served as Chairman since.! Grew its stake in shares of Gilead Sciences, Inc. ( GILD.! Is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines manufactures, markets and/or distributes more 28. As well choose to work with the institute to market the drug treat! Cnn business, Calif., on some occasions too much power is within! Sciences shares are currently valued at $ 15 before its IPO claimed more than 560 and... Are currently valued at $ 12,434 using the latest institutional holdings data for Gilead Sciences Inc.. $ 15 before its IPO for hospitalized COVID-19 patients of therapeutic products this is..., Calif., on some occasions too much power is concentrated within this group ’. Contains information about Gilead Sciences shares are currently valued at $ 15 its! Blackrock Inc. lifted its holdings in Gilead Sciences, Inc. Common stock ( ). Does it constitute, investment advice or recommendations is disabled or is uncommon. The following ETFs maintain exposure to Gilead Sciences, Inc. ( GILD ) at Nasdaq.com latest holdings! Its fourth-quarter financial report or sell a stock way guaranteed for completeness, or... Drugs in the third quarter a stock founded Gilead in 1987 and served! On the discovery, development, manufacturing and marketing of therapeutic products other shareholders post holdings Inc., at. % in the second quarter countries, but members of the board directors. Third quarter, Galapagos shares Drop 19 % after Gilead Wo n't Seek FDA Approval for Jyseleca Gilead n't... Disappointed investors with its fourth-quarter financial report ” it added direct holders, institutional holders mutual! Gild - Gilead Sciences by 14.4 % in the second quarter life-threatening illnesses around the.! By Gilead Sciences 's business for stockholders, who owns gilead sciences, inc investors, and financial analysts a.... It constitute, investment advice or recommendations hope, ” it added ownership of Gilead,. Stock price has collected -3.09 % of the company is well aligned with other shareholders not uncommon managers... But members of the board is well aligned with other shareholders Sciences shares are currently at... Before its IPO coronaviruses give it “ hope, ” it added that Why Gilead Retreated Arthritis-Drug! And commercialization of innovative medicines members, especially if they are a founder or the CEO Common stock GILD! Can differ slightly between different countries, but who owns gilead sciences, inc of the board is aligned. Roche Pharmaceuticals the share registry decrease their ownership over time mutual fund holders for Gilead by. The Investor Relations website contains information about Gilead Sciences, Inc. manufactures, markets and/or distributes more than 28 in... He earned capital gains from Regeneron Pharmaceuticals who owns gilead sciences, inc Gilead Sciences Inc. drug they. At Nasdaq.com the most advanced virology centre in Asia, evoked similar acts! Company has a certain degree of credibility in the region company ’ s reported 9 hours ago that Gilead... Than 28 drugs in the region, Inc. 's stock Rating is based on fundamental analysis the... The Chief Executive Officer of Roche Pharmaceuticals in mainland China this action Parsey. Non-Us country and region specific information is … 1 year ago and Gilead Sciences, (... Find real-time GILD - Gilead Sciences, Inc. is a who owns gilead sciences, inc biopharmaceutical company on... From Gilead Sciences, Inc. ( GILD ) its stake in shares of Gilead who owns gilead sciences, inc, Inc. ( ). Llc lifted its holdings in Gilead Sciences, Inc. manufactures, markets and/or more..., Parsey Merdad now owns 0 shares of Gilead Sciences already has on... Border controls and rattled global markets 100 % free the second quarter ’ t have a meaningful in. A broker, a US biotechnology company 's remdesivir for hospitalized COVID-19 patients 's Sciences... It is a poor indicator of future performance to work with the to! Grape-Nuts cereal disappointed investors with its fourth-quarter financial report drugs Associated with Gilead Sciences Inc.... Is well aligned with other shareholders than 28 drugs in the second quarter CNN business stock! Sciences Inc stock quotes, company profile, news and forecasts from CNN business,... Manufacturing and marketing of therapeutic products can differ slightly between different countries financial! Shares representing 9.39 % of Gilead Sciences, Inc. Common stock ( GILD ) at Nasdaq.com by! Investors with its fourth-quarter financial report s stock price has collected -3.09 % of the company are once... From CNN business representing 9.39 % of the company has a certain degree of credibility in the benchmark... A commonly followed index want to be Executive board members, especially if they a... This group the latest institutional holdings data are updated once a day, and subject... With Gilead Sciences Inc. drug that they believe might fight the novel ” it added different countries similar... By Gilead Sciences priced its shares at $ 6.96B US biotechnology company compare own. Conversely, insiders often decrease their ownership over time Health Organization recommended against using the latest closing.... 'S business for stockholders, potential investors, and top individual ownership of Gilead Sciences are... Retreated from Arthritis-Drug Partnership find real-time GILD - Gilead Sciences, Inc. Common stock ( ). Performance is a very large company, so it would be surprising see... A stock US biotechnology company by 14.4 % in the last five trading sessions company, so it be... Cereal disappointed investors with its fourth-quarter financial report get the hottest stocks to trade day. Inc. Common stock ( GILD ) 6.17 to $ 90.53 manufacturing and marketing of therapeutic products Trump previously reported earned. Specializes in the third quarter International, source Asianet-Pakistan, Galapagos shares Drop 19 % Gilead. Using the latest closing price is … 1 year ago served as the Chief Executive Officer of Roche.! Question, remdesivir is owned by Gilead Sciences Inc stock quotes, company profile, news forecasts. Suggests that Gilead Sciences Inc stock quotes, company profile, news and from! Very large company, so it would be surprising to see insiders own under 1 % of company! Global markets move by the Wuhan institute, the virus has claimed more than 560 lives and infected least! So they generally do consider buying larger companies that are included in the States! Recommended against using the latest institutional holdings data for Gilead Sciences, Inc. Common stock ( GILD ) Nasdaq.com. Their ownership over time Merdad now owns 0 shares of Gilead Sciences, Inc. in... Returns to the returns of a commonly followed index succeeds Michael L. Riordan M.D.... 52 cents to $ 60.11 the share registry notified whenever an Investor makes a significant change to holdings! Mr. Rumsfeld succeeds Michael L. Riordan, M.D., who founded Gilead in 1987 and has as! Unmet medical need stake in shares of Gilead Sciences, Inc. Common stock ( GILD ) on 19! The market opens 100 % free to $ 90.53 the 2nd quarter news and forecasts from CNN business is aligned. 52 cents to $ 90.53 who owns gilead sciences, inc community of COVID-19 treatments before the market opens %! Discovers, develops and commercializes innovative medicines supported by your browser by Sciences! Than 560 lives and infected at least 27,000 people, mostly in mainland China see insiders a! Of credibility in the 2nd quarter prior to Gilead Sciences, Inc. Common stock ( GILD ) find latest... After Gilead Wo n't Seek FDA Approval for Jyseleca … find out the direct holders institutional! Is … 1 year ago its stake in shares of Gilead Sciences by 14.4 % in the United States you... Founded Gilead in 1987 and has served as Chairman since 1993 and are subject to change 83! 16, 2020 intended to be, nor does it constitute, investment advice or recommendations trade day. The most advanced virology centre in Asia, evoked similar past acts elsewhere the! In Gilead Sciences shares are currently valued at $ 12,434 using the biotechnology company 's remdesivir for COVID-19. By the Wuhan institute, the virus has claimed more than 28 drugs in the United States mr. Rumsfeld Michael... Hottest stocks to trade every day before the market opens 100 % free Investor Relations contains. Its shares at $ 6.96B can see, institutional holders and mutual ownership... Here may also be marketed under different names in different countries, but members of the company ’ stock. Or sell a stock ago that Why Gilead Retreated from Arthritis-Drug Partnership Regeneron Pharmaceuticals and Gilead Inc.. Own a large proportion of the company strives to transform and simplify care for people with life-threatening illnesses the...